Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2022

Home Monitoring for AMD: 10 Years of Data

Michael J. Elman, MD

Show Description +

Michael J. Elman, MD, shares the long-term visual outcomes of AMD patients using the ForeseeHome Remote Telemonitoring system (Notal Vision).

Posted: 7/26/2022

Keywords:

ForeseeHome Remote Telemonitoring system

•

ForeseeHome

•

Notal Vision

•

Age-Related Macular Degeneration (AMD)

•

AMD

•

retina-meeting-recap

Up Next

A Call for Inclusion Efforts in Retina Clinical Trials

A Call for Inclusion Efforts in Retina Clinical Trials

Vivienne S. Hau, MD, PhD

Anti-VEGF Shows Promise for Treating Radiation Retinopathy

Anti-VEGF Shows Promise for Treating Radiation Retinopathy

Amy Schefler, MD

Faricimab in Wet AMD After 2 Years

Faricimab in Wet AMD After 2 Years

Arshad M. Khanani, MD, MA

Retinal Fluid Data Revealed for the PDS

Retinal Fluid Data Revealed for the PDS

Aleksandra V. Rachitskaya, MD, FASRS

High-Dose Aflibercept: Promising Results

High-Dose Aflibercept: Promising Results

Lloyd Clark, MD, FASRS

Dual Blockade Improves Durability for DME Treatment

Dual Blockade Improves Durability for DME Treatment

David Eichenbaum, MD

Back to All Videos

Home Monitoring for AMD: 10 Years of Data

Michael J. Elman, MD

Michael J. Elman, MD, shares the long-term visual outcomes of AMD patients using the ForeseeHome Remote Telemonitoring system (Notal Vision).

Posted: 7/26/2022

Keywords:

ForeseeHome Remote Telemonitoring system

•

ForeseeHome

•

Notal Vision

•

Age-Related Macular Degeneration (AMD)

•

AMD

•

retina-meeting-recap

Please log in to leave a comment.

More From ASRS: 2022 Coverage

Dual Blockade Improves Durability for DME Treatment

Dual Blockade Improves Durability for DME Treatment

David Eichenbaum, MD

A Call for Inclusion Efforts in Retina Clinical Trials

A Call for Inclusion Efforts in Retina Clinical Trials

Vivienne S. Hau, MD, PhD

Anti-VEGF Shows Promise for Treating Radiation Retinopathy

Anti-VEGF Shows Promise for Treating Radiation Retinopathy

Amy Schefler, MD

Faricimab in Wet AMD After 2 Years

Faricimab in Wet AMD After 2 Years

Arshad M. Khanani, MD, MA

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2022.